Etiology and initial investigation

Canadian Journal of Cardiology

Volumn 21, Issue SUPPL. B, 2005, Pages

  Skanes, Allan C ^a   Dorian, Paul ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Ablation; Arrhythmia; Atrial fibrillation; Cardioversion; Electrophysiology

Indexed keywords

ANTIARRHYTHMIC AGENT;

CARDIOVASCULAR RISK; COMORBIDITY; CONFERENCE PAPER; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HUMAN; MORBIDITY; PATHOGENESIS; PHYSICAL EXAMINATION; STROKE; THROMBOEMBOLISM;

ATRIAL FIBRILLATION; HUMANS; PRACTICE GUIDELINES;

EID: 34247402637     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Fuster V, Ryden LE, Asinger RW, et al; American College of Cardiology/American Heart Association/European Society of Cardiology Board. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation): Developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 2001;38:1231-66.
2. McNamara RL, Brass LM, Drozda JP, et al. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation. A report of the ACC/AHA task force on clinical data standards. Circulation 2004;3223-43.
3. Chen PS, Pressley JC, Tang AS, Packer DL, Gallagher JJ, Prystowsky EN. New observations on atrial fibrillation before and after surgical treatment in patients with the Wolff-Parkinson-White syndrome. J Am Coll Cardiol 1992;19:974-81.
4. Fischell TA, Stinson EB, Derby GC, Swerdlow CD. Long-term follow-up after surgical correction of Wolff-Parkinson-White syndrome. J Am Coll Cardiol 1987;9:283-7.
5. Haissaguerre M, Fischer B, Labbe T, et al. Frequency of recurrent atrial fibrillation after catheter ablation of overt accessory pathways. Am J Cardiol 1992;69:493-7.
6. Sharma AD, Klein GJ, Guiraudon GM, Milstein S. Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: Incidence after surgical ablation of the accessory pathway. Circulation 1985;72:161-9.
7. Hemmelgarn BR, Zarnke KB, Campbell NR, et al; Canadian Hypertension Education Program, Evidence-Based Recommendations Task Force. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I - blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2004;20:31-40.
8. Khan NA, McAlister FA, Campbell NR, et al; Canadian Hypertension Education Program. The 2004 Canadian recommendations for the management of hypertension: Part II - Therapy. Can J Cardiol 2004;20:41-54.
9. Brugada R, Tapscott T, Czernuszewicz GZ, et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997;336:905-11.
10. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989;1:175-9.
11. Singer DE, Hughes RA, Gress DR, et al. The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: The BAATAF Study. Am Heart J 1992;124:1567-73.
12. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991;18:349-55.
13. Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation 1991;84:527-39.
14. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study. N Engl J Med 1990;322:863-8.
15. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL. Stroke with intermittent atrial fibrillation: Incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 2000;35:183-7.
16. Krahn AD, Klein GJ, Kerr CR, et al. How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators. Arch Intern Med 1996;156:2221-4.
17. Klein AL, Grimm RA, Murray RD, et al; Assessment of Cardioversion Using Transesophageal Echocardiography Investigators. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001;344:1411-20.
18. Klein AL, Murray RD, Grimm RA. Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation. J Am Coll Cardiol 2001;37:691-704.
19. Tejan-Sie SA, Murray RD, Black IW, et al; ACUTE Investigators. Spontaneous conversion of patients with atrial fibrillation scheduled for electrical cardioversion: An ACUTE trial ancillary study. J Am Coll Cardiol 2003;42:1638-43.